Cargando…
Assessing metastasis risk after pre-operative anti-angiogenic therapy
Anti-angiogenic drugs are approved for the treatment of several cancer types, generally in the inoperable locally advanced or metastatic setting and in combination with other anti-cancer agents. Recent clinical studies also suggest that anti-angiogenic drugs can be useful in the pre-operative (neoad...
Autores principales: | Biziato, Daniela, De Palma, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287970/ https://www.ncbi.nlm.nih.gov/pubmed/25394647 http://dx.doi.org/10.15252/emmm.201404640 |
Ejemplares similares
-
Anti-tumour activity and store operated calcium entry: new roles in immunology
por: Singh, Kavisha, et al.
Publicado: (2013) -
Gaining the hard yard: pre-clinical evaluation of lentiviral-mediated gene therapy for the treatment of β-thalassemia
por: Milsom, Michael D, et al.
Publicado: (2010) -
A new twist to the emerging functions of ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis
por: Hannun, Yusuf A, et al.
Publicado: (2015) -
Neural stem cells for diabetes cell-based therapy
por: Basak, Onur, et al.
Publicado: (2011) -
Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer
por: Moserle, Lidia, et al.
Publicado: (2012)